

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer ce...
Q2 2026
Aug 11, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 9, 2026
Q4 2025
Mar 9, 2026
Q3 2025
Nov 12, 2025